// App-Quantinova.ai

323 : SKI-178, a single agent co-targeting sphingosine kinase 1 and microtubule dynamics, as a therapeutic strategy for treatment of acute myeloid leukemia

Researchers

Presenter

  • Taryn E. Dick

Principal Investigators

  • Jeremy A. Hengst

  • Laura M. Geffert

  • Robert F. Paulson

  • Hong-Gang Wang

  • David F. Claxton

  • Mark Kester

  • Thomas P. Loughran

  • Jong K. Yun

Medical Centers

  • Pennsylvania State University College of Medicine, Hershey, PA

  • Penn State University, University Park, State College, PA

  • University of Virgina, Charlottesville, VA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved